FL63ACGCN001
From Metabolomics.JP
(Difference between revisions)
| Line 1: | Line 1: | ||
{{Metabolite | {{Metabolite | ||
| − | |SysName=[(2R)-5,7-Dihydroxy-2alpha-(3,4-dihydroxyphenyl)-8-(2-pyrrolizinon-5-yl)chroman-3alpha-yl]beta-D-allopyranoside | + | |SysName= [ (2R) -5,7-Dihydroxy-2alpha- (3,4-dihydroxyphenyl) -8- (2-pyrrolizinon-5-yl) chroman-3alpha-yl ] beta-D-allopyranoside |
| − | |Common Name=&&Davallioside A&&[(2R)-5,7-Dihydroxy-2alpha-(3,4-dihydroxyphenyl)-8-(2-pyrrolizinon-5-yl)chroman-3alpha-yl]beta-D-allopyranoside&& | + | |Common Name=&&Davallioside A&& [ (2R) -5,7-Dihydroxy-2alpha- (3,4-dihydroxyphenyl) -8- (2-pyrrolizinon-5-yl) chroman-3alpha-yl ] beta-D-allopyranoside&& |
|CAS=131747-15-4 | |CAS=131747-15-4 | ||
|KNApSAcK=C00008973 | |KNApSAcK=C00008973 | ||
}} | }} | ||
Revision as of 09:00, 25 July 2008
| IDs and Links | |
|---|---|
| LipidBank | [1] |
| LipidMaps | [2] |
| CAS | 131747-15-4 |
| KEGG | {{{KEGG}}} |
| KNApSAcK | |
| CDX file | |
| MOL file | FL63ACGCN001.mol |
| Davallioside A | |
|---|---|
| |
| Structural Information | |
| Systematic Name | [ (2R) -5,7-Dihydroxy-2alpha- (3,4-dihydroxyphenyl) -8- (2-pyrrolizinon-5-yl) chroman-3alpha-yl ] beta-D-allopyranoside |
| Common Name |
|
| Symbol | |
| Formula | C25H29NO12 |
| Exact Mass | 535.1689753969999 |
| Average Mass | 535.4973 |
| SMILES | c(c(O)5)(c(O2)c(c(c5)O)CC(OC(C4O)OC(C(O)C4O)CO)C(c |
| Physicochemical Information | |
| Melting Point | |
| Boiling Point | |
| Density | |
| Optical Rotation | |
| Reflactive Index | |
| Solubility | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Chromatograms | |
Species Information
| Species-Flavonoid Relationship Reported | ||||||||
|---|---|---|---|---|---|---|---|---|
|
